Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: Scientific Reports

Volume: 11

Issue: 1

eISSN: 2045-2322

DOI: 10.1038/s41598-021-92623-z

Abstract:

Iron deficiency anaemia (IDA) is common in colorectal cancer (CRC), especially, in right-sided CRC which is known to have an overall worse prognosis. The associations between diagnostic pathway (Bowel Cancer Screening Programme (BCSP), IDA, symptomatic) and tumour side/stage was assessed using logistic regression models in 1138 CRC cases presenting during 2010–2016 at a single secondary-care centre in the UK. In the IDA sub-group, the relationship between CRC stage and the event of having a blood count prior to CRC diagnosis was examined using Bayesian parametric survival model. IDA was found as the only significant predictor of right-sided CRC (OR 10.61, 95% CI 7.02–16.52). Early-stage CRC was associated with both the IDA (OR 1.65, 95% CI 1.18–2.29) and BCSP pathway (OR 2.42, 95% CI 1.75–3.37). At any age, the risk of detecting CRC at late-stage was higher in those without a previous blood count check (hazard ratio 1.53, 95% credibility interval 1.08–2.14). The findings of this retrospective observational study suggest a benefit from diagnosing CRC through the detection of IDA, and warrant further research into the prognosis benefit of systematic approach to blood count monitoring of the at-risk population.

https://eprints.bournemouth.ac.uk/35727/

Source: Scopus

Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia.

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: Sci Rep

Volume: 11

Issue: 1

Pages: 13055

eISSN: 2045-2322

DOI: 10.1038/s41598-021-92623-z

Abstract:

Iron deficiency anaemia (IDA) is common in colorectal cancer (CRC), especially, in right-sided CRC which is known to have an overall worse prognosis. The associations between diagnostic pathway (Bowel Cancer Screening Programme (BCSP), IDA, symptomatic) and tumour side/stage was assessed using logistic regression models in 1138 CRC cases presenting during 2010-2016 at a single secondary-care centre in the UK. In the IDA sub-group, the relationship between CRC stage and the event of having a blood count prior to CRC diagnosis was examined using Bayesian parametric survival model. IDA was found as the only significant predictor of right-sided CRC (OR 10.61, 95% CI 7.02-16.52). Early-stage CRC was associated with both the IDA (OR 1.65, 95% CI 1.18-2.29) and BCSP pathway (OR 2.42, 95% CI 1.75-3.37). At any age, the risk of detecting CRC at late-stage was higher in those without a previous blood count check (hazard ratio 1.53, 95% credibility interval 1.08-2.14). The findings of this retrospective observational study suggest a benefit from diagnosing CRC through the detection of IDA, and warrant further research into the prognosis benefit of systematic approach to blood count monitoring of the at-risk population.

https://eprints.bournemouth.ac.uk/35727/

Source: PubMed

Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: SCIENTIFIC REPORTS

Volume: 11

Issue: 1

ISSN: 2045-2322

DOI: 10.1038/s41598-021-92623-z

https://eprints.bournemouth.ac.uk/35727/

Source: Web of Science (Lite)

Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: Scientific Reports

Volume: 11

Issue: 13055

Publisher: Nature Publishing Group

ISSN: 2045-2322

DOI: 10.1038/s41598-021-92623-z

Abstract:

Iron deficiency anaemia (IDA) is common in colorectal cancer (CRC), especially, in right-sided CRC which is known to have an overall worse prognosis. The associations between diagnostic pathway (Bowel Cancer Screening Programme (BCSP), IDA, symptomatic) and tumour side/stage was assessed using logistic regression models in 1138 CRC cases presenting during 2010–2016 at a single secondary-care centre in the UK. In the IDA sub-group, the relationship between CRC stage and the event of having a blood count prior to CRC diagnosis was examined using Bayesian parametric survival model. IDA was found as the only significant predictor of right-sided CRC (OR 10.61, 95% CI 7.02–16.52). Early-stage CRC was associated with both the IDA (OR 1.65, 95% CI 1.18–2.29) and BCSP pathway (OR 2.42, 95% CI 1.75–3.37). At any age, the risk of detecting CRC at late-stage was higher in those without a previous blood count check (hazard ratio 1.53, 95% credibility interval 1.08–2.14). The findings of this retrospective observational study suggest a benefit from diagnosing CRC through the detection of IDA, and warrant further research into the prognosis benefit of systematic approach to blood count monitoring of the at-risk population.

https://eprints.bournemouth.ac.uk/35727/

Source: Manual

Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia.

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: Scientific reports

Volume: 11

Issue: 1

Pages: 13055

eISSN: 2045-2322

ISSN: 2045-2322

DOI: 10.1038/s41598-021-92623-z

Abstract:

Iron deficiency anaemia (IDA) is common in colorectal cancer (CRC), especially, in right-sided CRC which is known to have an overall worse prognosis. The associations between diagnostic pathway (Bowel Cancer Screening Programme (BCSP), IDA, symptomatic) and tumour side/stage was assessed using logistic regression models in 1138 CRC cases presenting during 2010-2016 at a single secondary-care centre in the UK. In the IDA sub-group, the relationship between CRC stage and the event of having a blood count prior to CRC diagnosis was examined using Bayesian parametric survival model. IDA was found as the only significant predictor of right-sided CRC (OR 10.61, 95% CI 7.02-16.52). Early-stage CRC was associated with both the IDA (OR 1.65, 95% CI 1.18-2.29) and BCSP pathway (OR 2.42, 95% CI 1.75-3.37). At any age, the risk of detecting CRC at late-stage was higher in those without a previous blood count check (hazard ratio 1.53, 95% credibility interval 1.08-2.14). The findings of this retrospective observational study suggest a benefit from diagnosing CRC through the detection of IDA, and warrant further research into the prognosis benefit of systematic approach to blood count monitoring of the at-risk population.

https://eprints.bournemouth.ac.uk/35727/

Source: Europe PubMed Central

Evidence for improved prognosis of colorectal cancer diagnosed following the detection of iron deficiency anaemia.

Authors: Almilaji, O., Parry, S.D., Docherty, S. and Snook, J.

Journal: Scientific Reports

Volume: 11

Issue: 1

ISSN: 2045-2322

Abstract:

Iron deficiency anaemia (IDA) is common in colorectal cancer (CRC), especially, in right-sided CRC which is known to have an overall worse prognosis. The associations between diagnostic pathway (Bowel Cancer Screening Programme (BCSP), IDA, symptomatic) and tumour side/stage was assessed using logistic regression models in 1138 CRC cases presenting during 2010-2016 at a single secondary-care centre in the UK. In the IDA sub-group, the relationship between CRC stage and the event of having a blood count prior to CRC diagnosis was examined using Bayesian parametric survival model. IDA was found as the only significant predictor of right-sided CRC (OR 10.61, 95% CI 7.02-16.52). Early-stage CRC was associated with both the IDA (OR 1.65, 95% CI 1.18-2.29) and BCSP pathway (OR 2.42, 95% CI 1.75-3.37). At any age, the risk of detecting CRC at late-stage was higher in those without a previous blood count check (hazard ratio 1.53, 95% credibility interval 1.08-2.14). The findings of this retrospective observational study suggest a benefit from diagnosing CRC through the detection of IDA, and warrant further research into the prognosis benefit of systematic approach to blood count monitoring of the at-risk population.

https://eprints.bournemouth.ac.uk/35727/

Source: BURO EPrints